These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34026572)

  • 41. Sensitivity and applicability of the Brazilian version of the Brief Assessment of Cognition in Schizophrenia (BACS).
    Salgado JV; Carvalhaes CFR; Pires AM; Neves MCLD; Cruz BF; Cardoso CS; Lauar H; Teixeira AL; Keefe RSE
    Dement Neuropsychol; 2007; 1(3):260-265. PubMed ID: 29213399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients.
    Bralet MC; Falissard B; Neveu X; Lucas-Ross M; Eskenazi AM; Keefe RS
    Eur Psychiatry; 2007 Sep; 22(6):365-70. PubMed ID: 17434715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brief Clinical Assessment Scale for Schizophrenia (BCASS): Development, Validity, and Reliability Study.
    Yildiz M; Incedere A; Gürcan MB; Osman E
    Noro Psikiyatr Ars; 2022; 59(1):14-20. PubMed ID: 35317498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical global impression of cognition in schizophrenia (CGI-CogS): reliability and validity of a co-primary measure of cognition.
    Ventura J; Cienfuegos A; Boxer O; Bilder R
    Schizophr Res; 2008 Nov; 106(1):59-69. PubMed ID: 17900866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnostic structured interviews in child and adolescent's psychiatry].
    Renou S; Hergueta T; Flament M; Mouren-Simeoni MC; Lecrubier Y
    Encephale; 2004; 30(2):122-34. PubMed ID: 15107714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurocognitive Impairments (NCI) in bipolar disorder: Comparison with schizophrenia and healthy controls.
    Esan O; Oladele O; Adediran KI; Abiona TO
    J Affect Disord; 2020 Dec; 277():175-181. PubMed ID: 32829193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychometric properties of the Brief Version of the Schizotypal Personality Questionnaire in relatives of patients with schizophrenia-spectrum disorders and non-psychiatric controls.
    Compton MT; Chien VH; Bollini AM
    Schizophr Res; 2007 Mar; 91(1-3):122-31. PubMed ID: 17258893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Engel M; Fritzsche A; Lincoln TM
    Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How Can We Best Screen for Cognitive Impairment in Malaysia? A Pilot of the IDEA Cognitive Screen and Picture-Based Memory Impairment Scale and Comparison of Criterion Validity with the Mini Mental State Examination.
    Rosli R; Tan MP; Gray WK; Subramanian P; Mohd Hairi NN; Chin AV
    Clin Gerontol; 2017; 40(4):249-257. PubMed ID: 28459304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-Dementia Scale as a screening tool for the detection of subcortical cognitive deficits: validation of the Italian version.
    Montanucci C; Chipi E; Salvadori N; Rinaldi R; Eusebi P; Parnetti L
    J Neurol; 2021 Dec; 268(12):4789-4795. PubMed ID: 33991241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
    Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
    Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Screen for Cognitive Impairment in Psychiatry: Proposal for a polytomous scoring system.
    Gómez-Benito J; Berrío ÁI; Guilera G; Rojo E; Purdon S; Pino O
    Int J Methods Psychiatr Res; 2018 Sep; 27(3):e1598. PubMed ID: 29110352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia.
    Giordano GM; Palumbo D; Mucci A; Ventura J; Giuliani L; Perrottelli A; Bucci P; Rocca P; Rossi A; Bertolino A; Rucci P; Galderisi S; Maj M;
    Schizophr Res; 2022 Mar; 241():161-170. PubMed ID: 35124435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Apathy Evaluation Scale (AES-C): Psychometric Properties and Invariance of Italian Version in Mild Cognitive Impairment and Alzheimer's Disease.
    Furneri G; Platania S; Privitera A; Martelli F; Smeriglio R; Razza G; Maci T; Castellano S; Drago F; Santagati M; Caponnetto P; Caraci F; Di Nuovo S
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validity and reliability of two alternate versions of the Montreal Cognitive Assessment (Hong Kong version) for screening of Mild Neurocognitive Disorder.
    Wong A; Yiu S; Nasreddine Z; Leung KT; Lau A; Soo YOY; Wong LK; Mok V
    PLoS One; 2018; 13(5):e0196344. PubMed ID: 29791452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
    Engel M; Lincoln TM
    Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sahlgrenska Academy Self-reported Cognitive Impairment Questionnaire (SASCI-Q)--a research tool discriminating between subjectively cognitively impaired patients and healthy controls.
    Eckerström M; Skoogh J; Rolstad S; Göthlin M; Steineck G; Johansson B; Wallin A
    Int Psychogeriatr; 2013 Mar; 25(3):420-30. PubMed ID: 23207103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Associations between daily living skills, cognition, and real-world functioning across stages of schizophrenia; a study with the Schizophrenia Cognition Rating Scale Japanese version.
    Higuchi Y; Sumiyoshi T; Seo T; Suga M; Takahashi T; Nishiyama S; Komori Y; Kasai K; Suzuki M
    Schizophr Res Cogn; 2017 Mar; 7():13-18. PubMed ID: 28740824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subjectively-assessed cognitive impairment and neurocognition associations in schizophrenia inpatients.
    Masuzawa T; Hashimoto T; Yotsumoto K
    Schizophr Res Cogn; 2022 Mar; 27():100218. PubMed ID: 34631436
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.